>
Organization
Idera Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Idera Pharmaceuticals, Inc.

... of 2020 EXTON, Pa., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately ...
... due to merger-related costs associated with the company's terminated merger with Idera Pharmaceuticals, Inc. (Idera). Interest expense was $2.3 million in the third quarter of ...
... quarter - EXTON, Pa., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development and ultimate ...
... EXTON, Pa., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of ...
... Pennsylvania - EXTON, Pa., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of ...
... Eastern Time at the St. Regis Hotel in New York City. About Idera Pharmaceuticals Harnessing the approach of the earliest researchers in immunotherapy and Idera's ...
Subscribe now for full coverage on Idera Pharmaceuticals, Inc.
Start My Free Trial